ByQuoth the Raven:
(Editor’s Note: This article covers a stock trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.)
Celsion's OPTIMA Study: Key...
HCC Insurance Holdings, Inc. (HCC)
Q4 2013 Earnings Conference Call
February 12, 2014 09:00 ET
Chris Williams - Chief Executive Officer
Bill Burke - President
Brad Irick - Chief Financial Officer
Craig Kelbel -...
SAN FRANCISCO (MedPage Today) -- Patients with esophageal cancer derived no survival benefit with the addition of cetuximab to chemoradiation, while everolimus fared no better in a trial of patients with hepatocellular carcinoma (HCC) that had...
Cellular Biomedicine Group (OTC: CBMG) is pleased to announce that it has treated the final patient of its Phase I clinical trial which evaluates the safety and preliminary efficacy of TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for...
Oops! Unable to complete your request. Please refresh your browser.